EUDA Health Limited (EUDA)
NASDAQ: EUDA
· Real-Time Price · USD
2.55
-0.05 (-1.92%)
At close: Aug 15, 2025, 3:08 PM
EUDA Health Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2024 | Q1 2024 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Oct 31, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 954.02K | 954.02K | 1.11M | 1.7M | 2.43M | n/a | 2.43M | 2.67M | 2.69M | 2.69M | 2.52M | 2.64M |
Cost of Revenue | 732.99K | 732.99K | 809.08K | 1.3M | 1.62M | n/a | 1.77M | 1.4M | 1.58M | 1.7M | 1.51M | 1.51M |
Gross Profit | 221.04K | 221.04K | 298K | 403.6K | 817.63K | n/a | 660.64K | 1.27M | 1.11M | 995.13K | 1M | 1.13M |
Operating Income | -8.17M | -8.17M | -2.06M | -1.98M | -8.53M | -298.33K | -1.23M | -481.64K | -225.64K | -45.59K | -530 | -7.85K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16.31K | n/a | n/a | 1.9M |
Pretax Income | -8.38M | -8.37M | -6.1M | -2.41M | -22.63M | 201.01K | -1.02M | -472.99K | -224.89K | -45.59K | -528 | -7.85K |
Net Income | -8.41M | -8.41M | -6.1M | -2.41M | -22.51M | 201.01K | -1.02M | -472.99K | -224.89K | -45.59K | -528 | -7.85K |
Selling & General & Admin | 1.02M | 1.02M | 2.21M | 2.38M | 4.15M | 298.33K | 2.39M | 1.19M | 225.64K | 45.59K | 528.00 | 7.85K |
Research & Development | n/a | n/a | 16.62K | 2.95K | 2.15K | n/a | 7.2K | 2.95K | 50.63K | n/a | 36.85K | 41.79K |
Other Expenses | 7.38M | 7.38M | 124.66K | n/a | 7.03M | n/a | -21.14K | 145.54K | n/a | n/a | n/a | n/a |
Operating Expenses | 8.39M | 8.39M | 2.36M | 2.38M | 23.36M | 298.33K | 1.23M | 481.64K | 225.64K | 45.59K | 528.00 | 7.85K |
Interest Expense | n/a | n/a | 7.38K | 11.38K | 84.16K | n/a | 12K | 20.09K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 17.47K | 17.47K | 126.32K | 404.77K | 758.06K | n/a | 282.71K | 368.09K | 298.08K | 294.08K | 322.86K | 343.43K |
Cost & Expenses | 9.13M | 9.13M | 3.16M | 3.68M | 24.98M | 298.33K | 1.23M | 481.64K | 225.64K | 45.59K | 528.00 | 7.85K |
Income Tax Expense | 490.00 | 490.00 | -123 | 985.00 | 57.1K | n/a | 92.13K | 5.82K | 1.71K | n/a | 40.08K | 12.57K |
Shares Outstanding (Basic) | 28.51M | 28.51M | 22.06M | 20.19M | 11.55M | 11.07M | 11.07M | 11.07M | 10.67M | 9.64M | 7.42M | 7.42M |
Shares Outstanding (Diluted) | 28.37M | 28.37M | 22.06M | 20.19M | 11.55M | 11.07M | 11.07M | 11.07M | 10.67M | 9.64M | 7.42M | 7.42M |
EPS (Basic) | -0.29 | -0.29 | -0.28 | -0.12 | -1.95 | 0.02 | -0.09 | -0.04 | -0.02 | -0.00 | -0.00 | -0.00 |
EPS (Diluted) | -0.3 | -0.3 | -0.28 | -0.12 | -1.95 | 0.02 | -0.09 | -0.04 | -0.02 | -0.00 | -0.00 | -0.00 |
EBITDA | -789K | -788.98K | -6.09M | -2.36M | -8.49M | -695.55K | -1.7M | -481.64K | -143.25K | -303.54K | -356.05K | -219.88K |
EBIT | -795K | -794.73K | -6.09M | -2.4M | -8.53M | -726.05K | -1.76M | 75.31K | -224.89K | -45.59K | -528 | -7.85K |
Depreciation & Amortization | 5.75K | 5.75K | -4.03M | 42.48K | 44.1K | n/a | 51.55K | 54.05K | 56.19K | 44.52K | 51.67K | 53.13K |